Nautilus Biotechnology is a Seattle-based company that is developing a high-throughput, high-resolution platform to analyze and decode the human genome. The company’s mission is to transform the way we understand and diagnose disease by providing researchers and clinicians with a comprehensive understanding of the human genome. Nautilus’ technology combines nanofluidics, optics, and molecular biology to provide an unprecedented view of the genome, allowing for the discovery of new biomarkers, targets, and therapies. The company was founded in 2016 by a team of experienced entrepreneurs, scientists, and engineers with a shared vision of leveraging cutting-edge technology to unlock the full potential of the human genome.